MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET 2019-2027

Market By Therapeutic Application, Product, Analysis Purpose, End-user, Analysis Platform, Biomarker Type, Clinical Application And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s research report, the Middle East and African liquid biopsy market is anticipated to upsurge with a CAGR of 27.21% in the forecasting years of 2019-2027.

The report on the Middle East and Africa’s liquid biopsy market includes the countries of:

•           Saudi Arabia

•           Turkey

•           United Arab Emirates

•           South Africa

•           Rest of Middle East & Africa

Emerging economies have vast growth opportunities in the cancer biomarkers market, with the growing number of cancer patients & growing medical tourism in the developing countries such as India, China, Brazil and South Africa. The rising number of investments and government funds for the research & development in different fields are owing to the fastest growth of the cancer biomarkers in emerging economies. Rising healthcare expenditure, the incidence of growing cancer patients in emerging economies and increasing research on cancer have led the global cancer biomarkers market to grow.

Report scope can be customized per your requirements. Request For Customization

The adoption of non-invasive techniques for the treatment of cancer is increasing worldwide. However, most of the laboratory technicians are not qualified to perform the test. In addition, most of the individuals prefer non-invasive procedures for cancer biopsy tests, because of their benefits. Therefore, companies are providing training to surgeons to overcome this hurdle. There are no standard guidelines for liquid biopsy tests, which can hinder the market growth. Lab technicians play a major role, as they have to conduct the test with standardization and receive the correct results. Liquid biopsy is a part of molecular biology. Hence, the technicians need to learn about PCR techniques and assays. As there are no proper guidelines, the technicians need to receive training from the manufacturers of liquid biopsy.

Cintec Medical Ltd. is a medical device company that manufactures and markets mammography systems used for early detection of breast cancer. Its products comprise compression paddles, an optical marker, label printer, film writing device and a stereotactic biopsy system. Cintec’s mammography system is used for screening and diagnostic applications. The company’s paddles are used for imaging the axillary tail in extended views. Its film writing device records patient and exposure parameters directly on X-ray film through computerized data link from the system computer. Cintec is headquartered in Haifa, Israel.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET TRENDS

2.6. KEY LIQUID BIOPSY INITIATIVES

2.7. MARKET ATTRACTIVENESS INDEX

2.8. MARKET DRIVERS

2.8.1.   CANCER CASES IN OLDER POPULACE ARE SIGNIFICANTLY INCREASING

2.8.2.   DIAGNOSTIC CENTERS ARE IN DEMAND

2.8.3.   TISSUE/TUMOR-AGNOSTIC DRUGS USAGE ARE INCREASING

2.8.4.   RISE IN USAGE OF PRECISION MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   HIGH COST OF TEST

2.9.2.   LACK OF A CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPs)

2.10.            MARKET OPPORTUNITIES

2.10.1.                ADVANCEMENT IN TECHNOLOGY

2.10.2.                RISING NUMBER OF CANCER PATIENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF REIMBURSEMENT

2.11.2.                SKILLED PROFESSIONALS ARE QUITE LESS IN NUMBER

3.    LIQUID BIOPSY MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. PROSTATE CANCER

3.2. MELANOMA CANCER

3.3. BREAST CANCER

3.4. COLORECTAL CANCER

3.5. LUNG CANCER

3.6. OTHER TYPES OF CANCER

3.7. NON-ONCOLOGY APPLICATIONS

4.    LIQUID BIOPSY MARKET OUTLOOK - BY PRODUCT

4.1. CELL-FREE DNA (CFDNA)

4.2. CIRCULATING TUMOR CELLS (CTCS)

4.3. CIRCULATING TUMOR DNA (CTDNA)

4.4. EXTRACELLULAR VESICLES AND OTHERS

5.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PURPOSE

5.1. MONITORING

5.2. THERAPY GUIDANCE

5.3. EARLY DETECTION/SCREENING

5.4. DIAGNOSIS

6.    LIQUID BIOPSY MARKET OUTLOOK - BY END-USER

6.1. HOSPITALS

6.2. PHYSICIANS’ OFFICE LABORATORIES

6.3. CLINICAL DIAGNOSTIC LABORATORIES

7.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PLATFORM

7.1. MICROARRAY

7.2. NGS

7.3. PROTEOMICS

7.4. PCR

7.5. OTHER ANALYSIS PLATFORMS

8.    LIQUID BIOPSY MARKET OUTLOOK - BY BIOMARKER TYPE

8.1. NUCLEIC ACIDS

8.2. PROTEINS

8.3. EXTRACELLULAR VESICLES

8.4. CELLS

9.    LIQUID BIOPSY MARKET OUTLOOK - BY CLINICAL APPLICATION

9.1. TREATMENT MONITORING

9.2. PROGNOSIS & REOCCURRENCE MONITORING

9.3. TREATMENT SELECTION

9.4. DIAGNOSIS & SCREENING

10. LIQUID BIOPSY MARKET - REGIONAL OUTLOOK

10.1.            MIDDLE EAST AND AFRICA

10.2.            COUNTRY ANALYSIS

10.2.1.1.   SAUDI ARABIA

10.2.1.2.   TURKEY

10.2.1.3.   UNITED ARAB EMIRATES

10.2.1.4.   SOUTH AFRICA

10.2.1.5.   REST OF MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1.            AGILENT TECHNOLOGIES, INC.

11.2.            BOSTON SCIENTIFIC CORPORATION

11.3.            ARGON MEDICAL DEVICES, INC.

11.4.            B. BRAUN MELSUNGEN AG

11.5.            CINTEC MEDICAL LTD.

11.6.            ROCHE DIAGNOSTICS CORPORATION

11.7.            AD-TECH MEDICAL INSTRUMENT CORP.

11.8.            I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

11.9.            QIAGEN N.V.

11.10.         BECTON, DICKINSON

11.11.         PLANMECA OY

11.12.         BIO-RAD LABORATORIES, INC.

11.13.         CARDINAL HEALTH, INC.

11.14.         COOK MEDICAL, INC.

11.15.         FISCHER MEDICAL TECHNOLOGIES LLC

11.16.         C. R. BARD, INC. (ACQUIRED BY BECTON, DICKINSON AND COMPANY)

12. RESEARCH METHODOLOGY & SCOPE

12.1.            RESEARCH SCOPE & DELIVERABLES

12.1.1.                OBJECTIVES OF STUDY

12.1.2.                SCOPE OF STUDY

12.2.            SOURCES OF DATA

12.2.1.                PRIMARY DATA SOURCES

12.2.2.                SECONDARY DATA SOURCES

12.3.            RESEARCH METHODOLOGY

12.3.1.                EVALUATION OF PROPOSED MARKET

12.3.2.                IDENTIFICATION OF DATA SOURCES

12.3.3.                ASSESSMENT OF MARKET DETERMINANTS

12.3.4.                DATA COLLECTION

12.3.5.                DATA VALIDATION & ANALYSIS

List of table

TABLE 1        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

TABLE 2        LIQUID BIOPSY BIOMARKER CLASSES

TABLE 3        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 4        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 5        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 6        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 7        MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 8        ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS

TABLE 9        DROPLET DIGITAL PCR INDUSTRIES

TABLE 10      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 11      CELL DIFFERENTIATORS

TABLE 12      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 13      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 2      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PROSTATE CANCER 2019-2027 ($ MILLION)

FIGURE 3      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY MELANOMA CANCER 2019-2027 ($ MILLION)

FIGURE 4      TYPES OF BREAST CANCER

FIGURE 5      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BREAST CANCER 2019-2027 ($ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COLORECTAL CANCER 2019-2027 ($ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY LUNG CANCER 2019-2027 ($ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY OTHER TYPES OF CANCER 2019-2027 ($ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY NON-ONCOLOGY APPLICATION 2019-2027 ($ MILLION)

FIGURE 10   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CELL-FREE DNA (CFDNA) 2019-2027 ($ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR CELLS (CTCS) 2019-2027 ($ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR DNA (CTDNA) 2019-2027 ($ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES AND OTHERS 2019-2027 ($ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY MONITORING 2019-2027 ($ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPY GUIDANCE 2019-2027 ($ MILLION)

FIGURE 16   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY EARLY DETECTION/SCREENING 2019-2027 ($ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 18   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 19   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PHYSICIANS’ OFFICE LABORATORIES 2019-2027 ($ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CLINICAL DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 21   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 22   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 23   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PROTEOMICS 2019-2027 ($ MILLION)

FIGURE 24   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PCR 2019-2027 ($ MILLION)

FIGURE 25   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY OTHER ANALYSIS PLATFORM 2019-2027 ($ MILLION)

FIGURE 26   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY NUCLEIC ACIDS 2019-2027 ($ MILLION)

FIGURE 27   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PROTEINS 2019-2027 ($ MILLION)

FIGURE 28   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES 2019-2027 ($ MILLION)

FIGURE 29   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CELLS 2019-2027 ($ MILLION)

FIGURE 30   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY TREATMENT MONITORING 2019-2027 ($ MILLION)

FIGURE 31   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PROGNOSIS & REOCCURRENCE MONITORING 2019-2027 ($ MILLION)

FIGURE 32   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY TREATMENT SELECTION 2019-2027 ($ MILLION)

FIGURE 33   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY DIAGNOSIS & SCREENING 2019-2027 ($ MILLION)

FIGURE 34   SAUDI ARABIA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 35   TURKEY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 36   UNITED ARAB EMIRATES LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 37   SOUTH AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 38   REST OF MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;